Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient Ginkgo biloba leaf dry extract, (obg) ATC N06DP01 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code V for the active ingredient allergen extract from tree pollen (exclusively in the Dafo pump solution), Atc V01aa05 FDZ 01.01.25 - 31.12.26
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code V for the active ingredient apremilast, (obo) Atc L04aa32 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code V for the active ingredient rotigotine, (obg) ATC N04BC09 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient sevelamer hydrochloride, (obg) ATC V03ae02 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient dexamethasone (excluding implant), (obg) ATC S01ba01 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient pyridostigmine (excluding sustained-release Dafo.), (obg) ATC N07aa02 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient clindamycin + benzoyl peroxide, (obg) ATC D10af54 for the period 01.01.2025 - 31.12.2026
Closing Date5 Nov 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Guselkumab (ausschließlich In Der Wirkstärke 100mg), (obo), Atc L04ac16 Für Die Zeit 01.12.2024 - 30.11.2026
Closing Date5 Oct 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient glatiramer acetate (prefilled syringes only), (obo), Atc L03ax13 for the period 01.12.2024 - 30.11.2026
Closing Date5 Oct 2026
Tender AmountRefer Documents 
41-50 of 337 active Tenders